# Behavioral deficits and exacerbated neural and hemodynamic odor responses during lifespan of a mouse model of late onset Alzheimer’s disease expressing humanized APOEε4 and Trem2*R47H

**Authors:** Misha Izydorczak, Maggie Oumov, Mansiben V. Udhwani, Faysal Fostok, Guillermo Coronas-Samano, Basavaraju G. Sanganahalli, Peter Herman, Fahmeed Hyder, Justus V. Verhagen

PMC · DOI: 10.3389/fnagi.2026.1622135 · Frontiers in Aging Neuroscience · 2026-02-16

## TL;DR

This study examines a mouse model of late-onset Alzheimer’s disease to understand behavioral and neural changes linked to the condition.

## Contribution

The study confirms the translatability of the APOE4.TREM2 mouse model for late-onset Alzheimer’s disease.

## Key findings

- APOE4.TREM2 mice show exacerbated anxiety and deficits in odor-based foraging and spatial memory.
- Odor-evoked neural and intrinsic responses in the dorsal olfactory bulbs are heightened in these mice.
- Neurovascular coupling remains stable despite these neural changes.

## Abstract

Alzheimer’s disease (AD) poses a significant global health challenge, being the most prominent cause of dementia with prevalence increasing as the population ages. While the majority of AD cases are late-onset (LOAD), current animal models predominantly represent the more aggressive, faster progressing early-onset AD (EOAD), limiting their ability in assessing early biomarkers and gaining deeper understanding of LOAD progression. This study explores a promising translatable model, the APOE4.TREM2 mouse, which combines the APOE4 allele and the Trem2 p.R47H mutation, both linked to increased AD risk in the human population. We performed behavioral phenotyping and measured hemodynamics and neurovascular coupling in dorsal olfactory bulbs (dOB) during odor stimulation of the APOE4.TREM2 mouse line. Experimental evidence of olfactory dysfunction prior to clinical symptoms suggests the opportunity of utilizing smell testing and fMRI as tools for screening of AD, both for preclinical and clinical studies. Here we assess and confirm the translatability of the APOE4.TREM2 mouse LOAD model, reporting exacerbated anxiety, deficits in odor-based foraging and spatial memory, and exacerbated odor-evoked dOB neural and intrinsic responses, but stable neurovascular coupling, in an age-dependent manner.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348], TREM2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 54209]
- **Diseases:** Alzheimer’s disease (MONDO:0004975), dementia (MONDO:0001627)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, Etv3 (ets variant 3) [NCBI Gene 27049] {aka METS, Pe1}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 83433] {aka TREM-2, Trem2a, Trem2b, Trem2c}, App (amyloid beta precursor protein) [NCBI Gene 54226] {aka Abeta}, Tyrobp (TYRO protein tyrosine kinase binding protein) [NCBI Gene 22177] {aka DAP12, KARAP, Ly83}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Trem2 (triggering receptor expressed on myeloid cells 2) [NCBI Gene 301227] {aka Trem2-Mia, Trem2-Mib}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}
- **Diseases:** vascular dysfunction (MESH:D002561), brain dysfunction (MESH:D001927), deficits in episodic and spatial memory (MESH:D008569), cognitive impairment (MESH:D003072), Depression (MESH:D003866), sAD (MESH:D020821), Dementia (MESH:D003704), amyloid (MESH:C000718787), brain atrophy (MESH:C566985), MCI (MESH:D060825), AD (MESH:D000544), Anxiety (MESH:D001007), behavioral deficits (MESH:D019958), neurodegeneration (MESH:D019636), inflammation (MESH:D007249), anhedonia (MESH:D059445), sleep disturbances (MESH:D012893), PC (MESH:D015324), Vascular hyperactivity (MESH:D006948), motor deficits (MESH:D009461), synaptic (MESH:D012183), neurofibrillary tangles (MESH:D055956), Olfactory deficits (MESH:D000857), vascular, metabolic, and structural deficits (MESH:D020914), tau tangles (MESH:C536599), MODEL (MESH:D004195), memory and learning deficits (MESH:D007859)
- **Chemicals:** EB (MESH:C045572), Dexdomitor (MESH:D020927), Fluorescein isothiocyanate (-), PVDF (MESH:C024865), Krazy Glue (MESH:C029054), Ca (MESH:D002118), glucose (MESH:D005947), Ketamine (MESH:D007649), bupivacaine (MESH:D002045), Sucrose (MESH:D013395), FITC (MESH:D016650), MO (MESH:D008899), Carprofen (MESH:C007005), saline (MESH:D012965), AA (MESH:C005716), ethanol (MESH:D000431), cholesterol (MESH:D002784), PE (MESH:D010626), water (MESH:D014867), Atropine (MESH:D001285), Antisedan (MESH:C050701), isoflurane (MESH:D007530)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Musa acuminata (banana, species) [taxon 4641]
- **Mutations:** R47H, W 5000 K, W 500 K
- **Cell lines:** SJL — Mus musculus (Mouse), Finite cell line (CVCL_5897), A4T2 — Mus musculus (Mouse), Mouse myeloid leukemia, Cancer cell line (CVCL_2107)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950773/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950773/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950773/full.md

---
Source: https://tomesphere.com/paper/PMC12950773